IDXX241220P420000
- 5.40
- -1.60-22.86%
IDEXX Laboratories Inc Newsroom
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $559
Leerink Partners Initiates IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Announces Target Price $500
IDEXX Laboratories Analyst Ratings
Leerink Partners Initiates IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Announces Target Price $500
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $475
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $435 to $500
IDEXX Labs Is Maintained at Overweight by Barclays
IDEXX Laboratories Analyst Ratings
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $435
Piper Sandler Keeps Their Hold Rating on Idexx Laboratories (IDXX)
Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $481
BTIG Adjusts Price Target on IDEXX Laboratories to $500 From $580
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $559
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $475 to $589
Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $570
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $520
J.P. Morgan Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $575
JPMorgan Adjusts Price Target on IDEXX Laboratories to $575 From $630
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Laboratories Analyst Ratings